Browsing: taps

San Francisco-based Chai Discovery and Bristol Myers Squibb (NYSE: BMY) have announced a collaboration to apply Chai’s generative AI antibody discovery platform across BMS’s broader portfolio, with the stated goal of building an AI-powered, continuously learning discovery system at BMS. The deal covers antibody candidate identification across multiple undisclosed targets. Financial terms were not disclosed.

Core Natural Resources, Inc. (CNR) announced a planned leadership transition in its finance and operating functions. The board appointed Nathan Tucker as senior vice president and chief financial officer, effective immediately, succeeding Mitesh Thakkar in the CFO role. Thakkar will continue as president and is assuming an expanded role with day-to-day responsibility for the company’s…